Related Experiment Videos
Effects of propylthiouracil on MHV-3 virus mouse hepatitis
Research Communications in Chemical Pathology and Pharmacology
|January 1, 1982
Abstract:
A study was undertaken to observe the effect of propylthiouracil (PTU) on MHV-3 virus mouse hepatitis. PTU-treatment adversely influenced the course of the hepatitis. This effect was reflected by a significantly higher mortality rate, in spite of the absence of any significant difference of the plasma transaminase activity increase and of the liver virus content.
Insights
Propylthiouracil (PTU) worsened mouse hepatitis caused by MHV-3 virus, leading to higher mortality. This occurred despite no significant changes in liver enzymes or virus levels, indicating PTU
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Mouse hepatitis virus type 3 (MHV-3) is a common cause of liver inflammation in mice.
- Propylthiouracil (PTU) is an anti-thyroid drug with potential immunomodulatory effects.
Purpose of the Study:
- To investigate the impact of propylthiouracil (PTU) on the pathogenesis of MHV-3-induced mouse hepatitis.
Main Methods:
- Mice infected with MHV-3 were treated with PTU.
- Mortality rates, plasma transaminase activity, and liver viral content were assessed.
Main Results:
- PTU treatment resulted in a significantly higher mortality rate in MHV-3 infected mice.
- No significant differences were observed in plasma transaminase activity or liver viral load between PTU-treated and control groups.
- These findings suggest PTU exacerbates MHV-3 hepatitis independently of typical liver damage markers.
Conclusions:
- Propylthiouracil (PTU) has an adverse effect on MHV-3 mouse hepatitis, increasing mortality.
- The mechanism of PTU's detrimental effect may not be directly related to liver enzyme elevation or viral replication.